Rebecca Araujo

DocwireNews

<h3 class="entry-title">Is Myeloma Development Associated With Blood Type?<p>ABO blood groups may play a role in the development and outcomes of multiple myeloma, according to new data published in the&nbsp;<em>Magazine of European Medical Oncology</em>.&nbsp;A research team from Antalya Training and Research Hospital in Antalya, Turkey, conducted a retrospective, observational study to examine the relationship between blood type and&nbsp;<a href="https://www.docwirenews.com/docwire-pick/pesticide-exposure-linked-to-multiple-myeloma-precursor/" target="_blank" rel="noopener noreferrer">development</a>&nbsp;and clinical outcomes for this disease.</p><p>https://www.docwirenews.com/hematology-oncology/is-myeloma-development-associated-with-blood-type/</p><p>&ndash;</p><h3 class="entry-title">Dr. Camidge Discusses Launch of Phase 2 Trial Evaluating RAF/MEK Inhibitor in NSCLC</h3><p>Verastem Oncology recently announced the initiation of the second phase 2 registration-directed clinical trial from its RAMP (Raf And Mek Program). The study, RAMP 202, will evaluate VS-6766 (RAF/MEK inhibitor), alone and in combination with its FAK inhibitor (defactinib), for patients with KRAS-G12V mutant non-small cell lung cancer (NSCLC). Ross Camidge, MD, PhD, Director of Thoracic Oncology at the&nbsp;University of Colorado School of Medicineand Universityof Colorado Cancer Center, and Andrew Koustenis, Global Program Leader, Verastem Oncology, talked about the launch of the trial in an interview with DocWire News.</p><div>
<p>https://www.docwirenews.com/docwire-pick/hem-onc-picks/dr-camidge-discusses-launch-of-phase-2-trial-evaluating-raf-mek-inhibitor-in-nsclc/</p>
</div><div>&ndash;</div><h3 class="entry-title">Cancer Cells Hibernate to Evade Chemotherapy</h3><div class="td-module-meta-info">
<p>To survive&nbsp;<a href="https://www.docwirenews.com/conference-coverage/patients-cancer-chemotherapy/">chemotherapy</a>, cancer cells enter into a slow-dividing, hibernation-like state as a survival mechanism, according to a study published in the journal&nbsp;<em>Cell.</em></p>
<p>&ldquo;The tumor is acting like a whole organism, able to go into a slow-dividing state, conserving energy to help it survive,&rdquo; says Dr. Catherine O&rsquo;Brien, who is an Associate Professor in the Department of Surgery at the University of Toronto.</p>
<p>https://www.docwirenews.com/hematology-oncology/cancer-cells-hibernate-to-evade-chemotherapy/</p>
</div><div>&ndash;</div><div>
<h3 class="entry-title">Opioid Use May Be Linked to Pancreatic Cancer</h3>
</div><div class="td-module-meta-info">
<p>The use of opioids may increase an individual&rsquo;s risk of developing pancreatic cancer, according to a&nbsp;new study. Researchers aimed to determine associations between rates of <a href="https://www.docwirenews.com/hematology-oncology/study-evaluates-risk-factors-for-nonmedical-opioid-use-behavior-among-patients-with-cancer/" target="_blank" rel="noopener noreferrer">opioid use</a>&nbsp;and pancreatic cancer development in the United States between 1996 and 2016. Data on pancreatic cancer incidence rates in the U.S. were collected and compared with data on opioid-related mortality, a surrogate marker to account for both prescription and illicit opioid use.</p>
</div><div></div><div class="td-module-meta-info">
<p>https://www.docwirenews.com/docwire-pick/opioid-use-may-be-linked-to-pancreatic-cancer/</p>
<p>&nbsp;</p>
</div></h3>


Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Hatem Soliman, MD

Using Dendritic Cell Vaccines to Boost Neoadjuvant Therapy in HER2+ Breast Cancer

HER2 Breast Cancer

Kathleen Liu, MD

Joel M. Topf, MD, FACP

AKI Approaches and ASN Kidney Health Guidance

NKF Spring Clinical Meetings 2025

Latest News

Hem/Onc Roundup: Experts Discuss Phase 2 Trial of NSCLC Treatment, and More

Oncology

Is Myeloma Development Associated With Blood Type?
 ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe